Medibio Appoints Dr Thomas Young as CEO
- Mental health technology company Medibio (MEB) appoints Thomas Young as its new Chief Executive Officer, effective from today
- Dr Young will be employed on a part-time basis, receiving a total remuneration of US$110,000 (A$163,900) per annum
- Medi bio Non-Executive Director Dr Matt Mesnik says Dr Young’s background in mental health assessment is a tremendous asset to the company
- Dr Young will be employed on a part-time basis, receiving a total remuneration of US$110,000 (approximately A$163,983) per annum on the basis of 0.5 full-time equivalent hours
- Medi bio last traded at 0.2 cents at 3:06 pm AEST
